Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox.

Ko DT, Mamdani M, Alter DA.

JAMA. 2004 Apr 21;291(15):1864-70.

PMID:
15100205
2.
3.

Are high-risk hypertensive patients being prescribed concomitant statin therapy?: a retrospective cohort study.

Chapman RH, Petrilla AA, Berman L, Benner JS, Tang SS.

Am J Cardiovasc Drugs. 2009;9(5):299-308. doi: 10.2165/11312110-000000000-00000.

PMID:
19791839
5.

Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.

Corrao G, Conti V, Merlino L, Catapano AL, Mancia G.

Clin Ther. 2010 Feb;32(2):300-10. doi: 10.1016/j.clinthera.2010.02.004.

PMID:
20206788
6.

The efficiency of cardiovascular risk assessment: do the right patients get statin treatment?

van Staa TP, Smeeth L, Ng ES, Goldacre B, Gulliford M.

Heart. 2013 Nov;99(21):1597-602. doi: 10.1136/heartjnl-2013-303698.

7.

Statin treatment in a cohort of 20 212 men and women in Norway according to cardiovascular risk factors and level of education.

Selmer R, Sakshaug S, Skurtveit S, Furu K, Tverdal A.

Br J Clin Pharmacol. 2009 Mar;67(3):355-62. doi: 10.1111/j.1365-2125.2008.03360.x.

8.

Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.

Heintjes EM, Penning-van Beest FJ, Plat AW, Meerding WJ, Webb K, Sturkenboom MC, Herings RM.

Pharmacotherapy. 2012 Jul;32(7):631-41. doi: 10.1002/j.1875-9114.2011.01086.x.

PMID:
22760692
9.

Statin prescribing patterns in a cohort of cancer patients with poor prognosis.

Bayliss EA, Bronsert MR, Reifler LM, Ellis JL, Steiner JF, McQuillen DB, Fairclough DL.

J Palliat Med. 2013 Apr;16(4):412-8. doi: 10.1089/jpm.2012.0158.

10.

Individualized Risk Communication and Outreach for Primary Cardiovascular Disease Prevention in Community Health Centers: Randomized Trial.

Persell SD, Brown T, Lee JY, Shah S, Henley E, Long T, Luther S, Lloyd-Jones DM, Jean-Jacques M, Kandula NR, Sanchez T, Baker DW.

Circ Cardiovasc Qual Outcomes. 2015 Nov;8(6):560-6. doi: 10.1161/CIRCOUTCOMES.115.001723.

11.

Risk of incident diabetes among patients treated with statins: population based study.

Carter AA, Gomes T, Camacho X, Juurlink DN, Shah BR, Mamdani MM.

BMJ. 2013 May 23;346:f2610. doi: 10.1136/bmj.f2610. Erratum in: BMJ. 2013;347:f4356.

12.

Effectiveness of two statin prescribing strategies with respect to adherence and cardiovascular outcomes: observational study.

Wei L, MacDonald TM, Watson AD, Murphy MJ.

Pharmacoepidemiol Drug Saf. 2007 Apr;16(4):385-92.

PMID:
16998946
13.

Patterns and predictors of statin prescription in patients with type 2 diabetes.

Berthold HK, Gouni-Berthold I, Böhm M, Krone W, Bestehorn KP.

Cardiovasc Diabetol. 2009 May 13;8:25. doi: 10.1186/1475-2840-8-25.

14.
15.

Statin-associated incident diabetes: a literature review.

Park ZH, Juska A, Dyakov D, Patel RV.

Consult Pharm. 2014;29(5):317-34. doi: 10.4140/TCP.n.2014.317. Review.

PMID:
24849689
17.

Statin therapy in the reduction of cardiovascular events in patients undergoing intermediate-risk noncardiac, nonvascular surgery.

Raju MG, Pachika A, Punnam SR, Gardiner JC, Shishehbor MH, Kapadia SR, Abela GS.

Clin Cardiol. 2013 Aug;36(8):456-61. doi: 10.1002/clc.22135.

18.

National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project.

Krumholz HM, Radford MJ, Wang Y, Chen J, Heiat A, Marciniak TA.

JAMA. 1998 Aug 19;280(7):623-9. Erratum in: JAMA 1999 Jan 6;281(1):37.

PMID:
9718054
19.

Statin prescribing in the elderly in the Netherlands: a pharmacy database time trend study.

Geleedst-De Vooght M, Maitland-van der Zee AH, Schalekamp T, Mantel-Teeuwisse A, Jansen P.

Drugs Aging. 2010 Jul 1;27(7):589-96. doi: 10.2165/11537330-000000000-00000.

PMID:
20583852
20.

Effect of an intervention to increase statin use in medicare members who qualified for a medication therapy management program.

Stockl KM, Tjioe D, Gong S, Stroup J, Harada AS, Lew HC.

J Manag Care Pharm. 2008 Jul-Aug;14(6):532-40.

Items per page

Supplemental Content

Support Center